Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.


BACKGROUND Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved. METHODS We conducted an international, multicenter, randomized, double-blind, prospective trial involving 2776 patients, 50 to 80 years of age, who… (More)
DOI: 10.1056/NEJMoa0810177


7 Figures and Tables

Blog articles referencing this paper